QXO (QXO) had the highest return between 2012 and 2015 by a large-cap US stock, returning 6,137,800%.
| ASSET | YEARS | % RETURN |
|---|---|---|
QXO (QXO) | 2012-2015 | 6,137,800% |
Genmab A-S (GMAB) | 2012-2015 | 1,949.24% |
Netflix (NFLX) | 2012-2015 | 1,039.24% |
Alnylam Pharmaceuticals (ALNY) | 2012-2015 | 1,030.13% |
Regeneron Pharmaceuticals (REGN) | 2012-2015 | 860.66% |
DexCom (DXCM) | 2012-2015 | 760.29% |
Tesla (TSLA) | 2012-2015 | 729.35% |
Repligen (RGEN) | 2012-2015 | 717.63% |
Incyte (INCY) | 2012-2015 | 620.6% |
Constellation Brands Inc Class A (STZ) | 2012-2015 | 584.7% |
Neurocrine Biosciences (NBIX) | 2012-2015 | 547.25% |
Manhattan Associates (MANH) | 2012-2015 | 541.65% |
Delta Air Lines (DAL) | 2012-2015 | 530.18% |
Illumina (ILMN) | 2012-2015 | 519.19% |
IES (IESC) | 2012-2015 | 506.71% |
Insmed (INSM) | 2012-2015 | 481.73% |
Tyler Technologies (TYL) | 2012-2015 | 464.69% |
NXP Semiconductors (NXPI) | 2012-2015 | 433.9% |
Broadcom (AVGO) | 2012-2015 | 426.33% |
Southwest Airlines (LUV) | 2012-2015 | 407.17% |
Gilead Sciences (GILD) | 2012-2015 | 393.95% |
Corpay (CPAY) | 2012-2015 | 376.91% |
Skyworks Solutions (SWKS) | 2012-2015 | 362% |
U-Haul (UHAL) | 2012-2015 | 354.88% |
ICON (ICLR) | 2012-2015 | 348.1% |
Large-cap stocks are treated as having a market cap of $10B+.